| Trial ID: | L1900 |
| Source ID: | NCT02250794
|
| Associated Drug: |
Metformin And Sitagliptin
|
| Title: |
Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: metformin and sitagliptin|DRUG: insulin glargine and insulin lispro|DRUG: metformin and sitagliptin|DRUG: insulin glargine and insulin lispro
|
| Outcome Measures: |
Primary: mean blood glucose for the duration of the hospital stay, Participants will be followed for the duration of the hospital stay, an expected average of 5 days., duration of hospital stay | Secondary: frequency of hypoglycemia, Participants will be followed for the duration of the hospital stay, an expected average of 5 days. The outcome is the percent of patients having any blood glucose value less than 70 mg/dl during their hospital stay., duration of hospital stay | Other: Acute kidney injury, Participants will be followed for the duration of the hospital stay, an expected average of 5 days. The outcome is the percent of patients who develop acute kidney injury during their hospital stay. Acute kidney injury is defined as an absolute increase in the serum creatinine concentration of ≥ 0.3 mg/dL from baseline or a percentage increase in the serum creatinine concentration of ≥ 50%, duration of hospital stay
|
| Sponsor/Collaborators: |
Sponsor: Rush University Medical Center
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2014-10
|
| Completion Date: |
2015-05
|
| Results First Posted: |
|
| Last Update Posted: |
2021-10-11
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT02250794
|
